These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3804904)

  • 21. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of skin and soft tissue infections with cefadroxil, a new oral cephalosporin.
    Cordero A
    J Int Med Res; 1976; 4(3):176-8. PubMed ID: 1026545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
    Bradsher RW; Snow RM
    Am J Med; 1984 Oct; 77(4C):63-7. PubMed ID: 6093522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral ciprofloxacin for treatment of severe infections.
    Lobo IM; Silva NF; Assef MC; Mangini C; Silva ML; Bortoletto ML; Mendonça JS; Levi GC
    Int J Clin Pharmacol Res; 1993; 13(2):81-5. PubMed ID: 8354593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group.
    Davis C
    Clin Ther; 1994; 16(3):505-21. PubMed ID: 7923317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin and soft-tissue infections.
    Finch R
    Lancet; 1988 Jan; 1(8578):164-8. PubMed ID: 2892996
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical experience with doxycycline in the treatment of surgical soft-tissue infections.
    Marks G; Mervine TB
    Curr Ther Res Clin Exp; 1974 May; 16(5):424-30. PubMed ID: 4209058
    [No Abstract]   [Full Text] [Related]  

  • 28. Cefprozil versus cefaclor in the treatment of mild to moderate skin and skin-structure infections. The Cefprozil Multicenter Study Group.
    Parish LC; Doyle CA; Durham SJ; Wilber RB
    Clin Ther; 1992; 14(3):458-69. PubMed ID: 1638587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective, controlled, randomized non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of skin or soft-tissue infections.
    Dominguez J; Palma F; Vega ME; Magaña JL; Ortiz G; Teresa-Hojyo M; Dominguez L
    Am J Med; 1989 Nov; 87(5A):136S-137S. PubMed ID: 2686414
    [No Abstract]   [Full Text] [Related]  

  • 30. Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime.
    Parish LC; Asper R
    Am J Med; 1987 Apr; 82(4A):227-9. PubMed ID: 3555041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
    Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
    Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical experience with ciprofloxacin: analysis of a multicenter study.
    Simmons JF; Cowley CE; Dozier DB; Galdini AM; Manes MR; Nungester GH; Schreeder MT; Strother KD; Chun BW
    Ala Med; 1989 Feb; 58(8):10-3. PubMed ID: 2646874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ampicillin/sulbactam versus cefazolin or cefoxitin in the treatment of skin and skin-structure infections of bacterial etiology.
    Chan JC
    Adv Ther; 1995; 12(2):139-46. PubMed ID: 10150324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clindamycin and cloxacillin compared in the treatment of skin and soft-tissue infections.
    Pusponegoro EH; Wiryadi BE
    Clin Ther; 1990; 12(3):236-41. PubMed ID: 2379228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of intravenous ciprofloxacin in difficult-to-treat infections.
    Giamarellou H; Galanakis N
    Am J Med; 1987 Apr; 82(4A):346-51. PubMed ID: 3555059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral ciprofloxacin therapy for infections in cancer patients.
    Haron E; Rolston KV; Cunningham C; Holmes F; Umsawasdi T; Bodey GP
    J Antimicrob Chemother; 1989 Dec; 24(6):955-62. PubMed ID: 2516086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.
    Gentry LO; Ramirez-Ronda CH; Rodriguez-Noriega E; Thadepalli H; del Rosal PL; Ramirez C
    Arch Intern Med; 1989 Nov; 149(11):2579-83. PubMed ID: 2684078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral ciprofloxacin treatment of infections in geriatric patients.
    Yangco BG; Kenyon VS; Halkias KD; Bogel JA; Toney JF; Chmel H
    Clin Ther; 1989; 11(4):503-10. PubMed ID: 2776166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin.
    Scully BE; Jules K; Chin NX; Neu HC
    Am J Med; 1987 Apr; 82(4A):336-8. PubMed ID: 3578324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ciprofloxacin in severe infections.
    Aswapokee N; Pruksachatvuthi S; Aswapokee P
    J Med Assoc Thai; 1990 Jun; 73(6):315-20. PubMed ID: 2230626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.